Ladder Bio: Valuation, Funding & Investors
Ladder Bio is a therapeutics company developing Spiroligomer(TM) ladder-shaped peptide-like molecules--sequence-defined, structurally preorganized molecules designed to be orally available, cell permeable, and engage challenging biological targets with high affinity and selectivity. Ladder Bio's platform integrates rational design with modern discovery to create new treatment options for patients where conventional modalities fall short.
Leadership & Board
- Current Number of Employees
- 17
- Current LinkedIn Followers
- 693
Latest Estimated Valuation
- Total Amount Raised
- $6M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $6M
- Latest Funding Round
- Seed Round
Employee Trend
Ladder Bio had 17 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Ladder Bio had 693 followers as of November 9, 2026. The number of followers increased by 2 (0.29%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 12, 2025 | Seed Round | $5.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Medical Excellence Capital | Seed Round |
| Hatch BioFund | Seed Round |
Similar Companies
A snapshot of private companies similar to Ladder Bio, helping you discover and navigate related company profiles.
